S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 194 SEK 0.78%
Market Cap: kr1.7B

Stille AB
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Stille AB
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Research & Development
-kr21m
CAGR 3-Years
72%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Research & Development
-kr191.4m
CAGR 3-Years
-7%
CAGR 5-Years
-81%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Research & Development
-kr97.6m
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
-14%
Getinge AB
STO:GETI B
Research & Development
-kr1.3B
CAGR 3-Years
-8%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Research & Development
-kr140m
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.7B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
203.48 SEK
Undervaluation 5%
Intrinsic Value
Price
S

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett